FindTrial
Sign In

To evaluate analgesic efficacy of dexamethasone, a steroid as an adjuvant to Ropivacaine, a local anaesthetic in pectoral nerve block in breast surgery patients

To evaluate analgesic efficacy of dexamethasone as an adjuvant to Ropivacaine in pectoral nerve block.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014739
Enrollment
60
Registered
2018-07-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Carcinoma breast females undergoing unilateral modified radical mastectomy.

Interventions

Intervention1: dexamethasone as an adjuvant to ropivacaine in pectoral nerve block.: To evaluate analgesic efficacy of dexamethasone as an adjuvant to ropivacaine in pectoral nerve block. Intervention

Sponsors

Arshdeep Kaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II. Female with age >18 years, giving valid informed and written consent. Patient undergoing unilateral MRM under general anesthesia

Exclusion criteria

Exclusion criteria: Patient refusal. Patients with any contraindication to regional anaesthesia or allergy to the study drug. ASA III or ASA IV patients. Pregnant or lactating patients.

Design outcomes

Primary

MeasureTime frame
The duration of postoperative analgesia, total analgesic consumption in 24 hours in both the groups.Timepoint: every hour till first 12 hours and them at 18hr and 24hr.—

Secondary

MeasureTime frame
patient sedation score and side effects if any.Timepoint: every hour till first 12 hours and them at 18hr and 24hr.—

Countries

India

Contacts

Public ContactDrHaramritpal Kaur

GGS Medical College and Hospital, Faridkot

amritk_dr@yahoo.co.in9878088013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026